Business Wire

PA-PROJECT-MANAGEMENT

21.10.2020 15:02:12 CEST | Business Wire | Press release

Share
Project Management Institute Launches Initial Products in Industry’s First Platform-Agnostic Suite of Resources to Accelerate Adoption of Citizen Development at Scale

Project Management Institute (PMI), the world’s leading association for the project management profession, today launched the industry’s first, platform-agnostic educational resources for organizations seeking to implement and scale Citizen Development (CD) practices. The first two products in a planned suite of offerings are available now:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201021005531/en/

  • The PMI Citizen Development Body of Knowledge (CDBOK™) is a centralized resource that will help individuals and enterprises understand best practices for implementing citizen development within an organization at scale.
  • The foundational training course is an e-learning training program that provides an introduction to citizen development and outlines best practices in CD methodologies.

Citizen development platforms use intuitive “low-code” and “no-code” tools, so that even non-technical, non-specialist employees can create apps, software solutions and even enterprise-grade applications without having to learn to code. The emergence of citizen development promises to improve enterprise productivity by making application and software development significantly faster and less costly, while also accelerating value delivery and enabling organizations to achieve outcomes more quickly.

“PMI is ideally positioned to help drive adoption of citizen development,” says Sunil Prashara, PMI President and CEO. “As the world’s leading not-for-profit association for the project management profession, we’ve spent the past 50 years equipping our stakeholders with the most relevant skills and resources so they can deliver change and business value, all to help their organizations succeed. To ensure we are providing the right tools for citizen development, we have tapped leading experts in the field and combined their knowledge and expertise with our own deep experience developing global standards and certification training for project managers all around the world. With more than 600,000 members and 1.5 million gross credential holders in nearly every country, we can serve as an objective resource for organizations and individuals looking to apply citizen development tools and methodologies thoughtfully and with confidence.”

Citizen Development Helps Pave the Way for the Next Wave of Business Transformation

Citizen development should ease the burden on over-taxed IT departments straining to cope with growing demands for support from business units. Forrester Research estimates that by 2024 the U.S. will have a deficit of 500,000 software developers.

“Citizen development will form the next wave of business transformation,” says Mr. Prashara. “Technological advances such as AI are eliminating much of the complexity involved in software development, allowing non-specialists to create their own solutions and bring new products and services to market in unprecedented timeframes. This will democratize software development and turbocharge digital transformation efforts.”

Citizen development enables a “hyper-agile” way of working, which can lead to substantial reductions in cost and development times. With citizen development, the speed at which you can take an idea and design, build, test and deploy apps enables teams and organizations to deliver projects and bring products and services to market faster than ever before.

Scaling Citizen Development at the Enterprise Level, Safely and Securely with PMI

Gartner estimates that the number of active citizen developers will be four times that of professional developers by 2023. PMI’s new suite of products should help facilitate that transition, allowing organizations to promote citizen development among their employees in a measured and secure way.

According to Gartner, 41 percent of business leaders report having active citizen development initiatives underway, with 20 percent either evaluating or planning to start CD initiatives. However, to derive maximum benefit from citizen development, organizations will need to scale it across the enterprise, creating an organizational operating system. There is an urgent need to enable this level of scalability in order to drive transformation efforts, Mr. Prashara says, and that was the driving force behind developing the new PMI offerings.

“PMI recognizes the critical role that citizen development plays in empowering individuals and organizations,” Mr. Prashara says. “As organizations look to leverage citizen development in their digital transformation programs, there are many pitfalls to avoid, including the lack of a comprehensive methodology and framework and adequate training to allow citizen developers to succeed. PMI is addressing this gap by providing a vendor-agnostic framework to support professionals’ need to learn the basics and best practices, but also organizations’ need to unlock the potential of citizen development in compliance with IT governance and security. This will give IT the confidence to scale citizen development across the enterprise to accelerate the organization’s transformation efforts.”

PMI Citizen Developer Products & Experiences in the Pipeline

While the initial offerings are available now, PMI will launch additional PMI Citizen Developer products in the coming months, to include specific role-based courses and certifications, as well as a community portal for sharing CD information and thought leadership. The PMI Citizen Development Body of Knowledge (CDBOK™) will also be followed by an executive book on CD best practices, highlighting specific case studies and leadership perspectives.

To learn how to unlock the potential of citizen development at your organization, go to: pmi.org/citizen-developer .

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute.

Social Media:

https://www.facebook.com/PMInstitute

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye